Overview

Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis

Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, double-blind, placebo-controlled, phase 4 clinical trial to evaluate the efficacy and safety of andrographolide sulfonate in patients with acute bronchitis
Phase:
Phase 4
Details
Lead Sponsor:
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Treatments:
Andrographolide